Back to Awarded Treatment Trials
Awarded Trial: 97-RC-299-15
Grant ID
97-RC-299-15
Illness
Bipolar Depression
Primary Drug/Intervention
Secretin
Primary Dosage
1.0 mg/kg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Cancelled
Investigator
Cohen
Sample Size
12
Duration of Study Period for Each Subject
2 weeks
Outcome Measurements
YMRS, MADRS, HAM-D, CGI-BP, PANSS
Results
N/A
Publication
N/A
Link
N/A
PI Name
Bruce Cohen
Degree
MD
Center
N/A
Institution
N/A
Address
N/ACity or Town
Belmont
State or Province
MA
Zip or Postal Code
N/A
Country
USA
Email Address
cohenb@mclean.harvard.edu